Lupin announced that it has received approval for its Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food and Drug Administration (FDA) to market a generic version of Mylan Pharmaceuticals, Inc.'s (Mylan) Triamcinolone Acetonide Ointment, 0.1%.
Lupin's Triamcinolone Acetonide Ointment USP, 0.1% is the generic version of Mylan's Triamcinolone Acetonide Ointment, 0.1% It is indicated for the relief of the inflammatory and pruritic manifestations of cortico steroid responsive dermatoses.
Triamcinolone Acetonide Ointment USP, 0.1% had annual sales of approximately USD 25.7 million in the US (IQVIA MAT June 2018).
Shares of LUPIN LTD. was last trading in BSE at Rs.877.6 as compared to the previous close of Rs. 895.4. The total number of shares traded during the day was 139961 in over 3617 trades.
The stock hit an intraday high of Rs. 905.25 and intraday low of 859.2. The net turnover during the day was Rs. 123584151.